Loading...
Sorafenib and sunitinib: A dermatologist's perspective
Sorafenib and sunitinib are inhibitors of tumor angiogenesis have recently generated curiosity regarding its role in cutaneous toxicities, which has severely affected the daily activities resulting in interruption or dose modification of therapy in renal cell carcinoma and hepatocellular carcinomas....
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Medknow Publications & Media Pvt Ltd
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3937473/ https://ncbi.nlm.nih.gov/pubmed/24616845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2229-5178.126017 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|